Key result
Cardiac arrest mortality with co-listed IHD in older adults remained stable despite a pandemic-era increase.
Why the study?
Long-term trends in cardiac arrest-associated mortality with co-listed ischemic heart disease among older U.S. adults had not been fully evaluated.
Observational (n=1,050,867)
Effect estimate: AAPC +0.07%
Cardiac arrest-associated mortality with co-listed ischemic heart disease in older U.S. adults remained stable from 1999 to 2024, characterized by a pandemic-era spike and subsequent incomplete recovery.
Mortality stability warrants ongoing surveillance in older adults; leaves open drivers of incomplete pandemic recovery.
This population based retrospective study examined long-term trends in cardiac arrest associated mortality with co listed ischemic heart disease among U.S. adults aged ≥65 years from 1999 through 2024 using CDC WONDER Multiple Cause of Death data. Mortality trends were evaluated using age-adjusted mortality rates, annual percent changes (APC), and average annual percent change (AAPC) with Joinpoint regression. An ARIMA model was used to project mortality through 2030. A total of 1,050,867 deaths were identified. Overall mortality remained relatively stable across the study period (AAPC +0.07%), with a marked increase from 2018–2021 (APC +9.93%) followed by a decline from 2021–2024 (APC −7.30%). Men had higher age-adjusted mortality rates than women throughout the study period. The ARIMA model projected an age-adjusted mortality rate of 98.8 per 100,000 by 2030 (95% prediction interval, 80.9–116.8). These findings demonstrate stable long-term mortality with a pronounced pandemic-era increase followed by an incomplete recovery, highlighting the continued burden of cardiac arrest–associated mortality among older U.S. adults with co-listed ischemic heart disease.
No takes yet. Share an insight, caveat, or question.
Radhakrishnan et al. (2026) conducted an observational in Cardiac arrest with co-listed ischemic heart disease (n=1,050,867). Time period (1999-2024) was evaluated on Cardiac arrest associated mortality (AAPC +0.07%). Cardiac arrest-associated mortality with co-listed ischemic heart disease among older U.S. adults remained stable from 1999-2024 (AAPC +0.07%), despite a marked pandemic-era increase.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: